BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31914218)

  • 1. Utility of the global CDR
    Miyagawa T; Brushaber D; Syrjanen J; Kremers W; Fields J; Forsberg LK; Heuer HW; Knopman D; Kornak J; Boxer A; Rosen HJ; Boeve BF; Appleby B; Bordelon Y; Bove J; Brannelly P; Caso C; Coppola G; Dever R; Dheel C; Dickerson B; Dickinson S; Dominguez S; Domoto-Reilly K; Faber K; Ferrell J; Fishman A; Fong J; Foroud T; Gavrilova R; Gearhart D; Ghazanfari B; Ghoshal N; Goldman JS; Graff-Radford J; Graff-Radford N; Grant I; Grossman M; Haley D; Hsiung R; Huey E; Irwin D; Jones D; Jones L; Kantarci K; Karydas A; Kaufer D; Kerwin D; Kraft R; Kramer J; Kukull W; Litvan I; Lucente D; Lungu C; Mackenzie I; Maldonado M; Manoochehri M; McGinnis S; McKinley E; Mendez MF; Miller B; Multani N; Onyike C; Padmanabhan J; Pantelyat A; Pearlman R; Petrucelli L; Potter M; Rademakers R; Ramos EM; Rankin K; Rascovsky K; Roberson ED; Rogalski E; Sengdy P; Shaw L; Tartaglia MC; Tatton N; Taylor J; Toga A; Trojanowski JQ; Wang P; Weintraub S; Wong B; Wszolek Z
    Alzheimers Dement; 2020 Jan; 16(1):106-117. PubMed ID: 31914218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium.
    Miyagawa T; Brushaber D; Syrjanen J; Kremers W; Fields J; Forsberg LK; Heuer HW; Knopman D; Kornak J; Boxer A; Rosen H; Boeve B;
    Alzheimers Dement; 2020 Jan; 16(1):79-90. PubMed ID: 31477517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the Japanese version of the Clinical Dementia Rating® plus National Alzheimer's Coordinating Centre Behaviour and Language Domains for sporadic cases of frontotemporal dementia in Japan.
    Taomoto D; Sato S; Kanemoto H; Suzuki M; Hirakawa N; Takasaki A; Akimoto M; Satake Y; Koizumi F; Yoshiyama K; Takahashi R; Shigenobu K; Hashimoto M; Miyagawa T; Boeve B; Knopman D; Mori E; Ikeda M
    Psychogeriatrics; 2024 Mar; 24(2):281-294. PubMed ID: 38152057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining Associations Between Smartphone Use and Clinical Severity in Frontotemporal Dementia: Proof-of-Concept Study.
    Paolillo EW; Casaletto KB; Clark AL; Taylor JC; Heuer HW; Wise AB; Dhanam S; Sanderson-Cimino M; Saloner R; Kramer JH; Kornak J; Kremers W; Forsberg L; Appleby B; Bayram E; Bozoki A; Brushaber D; Darby RR; Day GS; Dickerson BC; Domoto-Reilly K; Elahi F; Fields JA; Ghoshal N; Graff-Radford N; G H Hall M; Honig LS; Huey ED; Lapid MI; Litvan I; Mackenzie IR; Masdeu JC; Mendez MF; Mester C; Miyagawa T; Naasan G; Pascual B; Pressman P; Ramos EM; Rankin KP; Rexach J; Rojas JC; VandeVrede L; Wong B; Wszolek ZK; Boeve BF; Rosen HJ; Boxer AL; Staffaroni AM;
    JMIR Aging; 2024 Jun; 7():e52831. PubMed ID: 38922667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort.
    Peakman G; Russell LL; Convery RS; Nicholas JM; Van Swieten JC; Jiskoot LC; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Le Ber I; Tagliavini F; Santana I; Pasquier F; Levin J; Danek A; Otto M; Sorbi S; Rohrer JD;
    J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):158-168. PubMed ID: 34353857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia.
    Samra K; Peakman G; MacDougall AM; Bouzigues A; Greaves CV; Convery RS; van Swieten JC; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Ber IL; Tiraboschi P; Santana I; Pasquier F; Levin J; Otto M; Sorbi S; Rohrer JD; Russell LL;
    Alzheimers Dement (Amst); 2024; 16(2):e12571. PubMed ID: 38623386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Cognitive Changes in Genetic Frontotemporal Dementia Within the GENFI Cohort.
    Poos JM; MacDougall A; van den Berg E; Jiskoot LC; Papma JM; van der Ende EL; Seelaar H; Russell LL; Peakman G; Convery R; Pijnenburg YAL; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Doré MC; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; Mendonça A; Tiraboschi P; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Le Ber I; Pasquier F; van Swieten J; Rohrer JD;
    Neurology; 2022 Jul; 99(3):e281-e295. PubMed ID: 35483895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portuguese version of the CDR plus NACC FTLD: Validation studies.
    Lima M; Tábuas-Pereira M; Durães J; Faustino P; Simões MR; Kukull W; Knopman DS; Santana I
    Alzheimers Dement (Amst); 2022; 14(1):e12355. PubMed ID: 36466956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study.
    Borroni B; Agosti C; Premi E; Cerini C; Cosseddu M; Paghera B; Bellelli G; Padovani A
    Eur J Neurol; 2010 May; 17(5):703-7. PubMed ID: 20050899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Progression in Frontotemporal Dementia and Alzheimer Disease: The Contribution of Staging Scales.
    Lima-Silva TB; Mioshi E; Bahia VS; Cecchini MA; Cassimiro L; Guimarães HC; Gambogi LB; Caramelli P; Balthazar M; Damasceno B; Brucki SMD; de Souza LC; Nitrini R; Yassuda MS
    J Geriatr Psychiatry Neurol; 2021 Sep; 34(5):397-404. PubMed ID: 32762416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement and characterization of distinctive clinical phenotypes using the Frontotemporal Lobar Degeneration Module (FTLD-MOD).
    Gefen T; Teylan MA; Besser L; Pollner E; Moshkovich A; Weintraub S
    Alzheimers Dement; 2020 Jun; 16(6):918-925. PubMed ID: 32400973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Differences in Clinical Presentation in Individuals Diagnosed With Frontotemporal Dementia.
    Jin HA; McMillan CT; Yannatos I; Fisher L; Rhodes E; Jacoby SF; Irwin DJ; Massimo L
    JAMA Neurol; 2023 Nov; 80(11):1191-1198. PubMed ID: 37695629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS.
    Rosen HJ; Boeve BF; Boxer AL
    Alzheimers Dement; 2020 Jan; 16(1):71-78. PubMed ID: 31914219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the Spanish version of the FTLD-modified CDR in the diagnosis and staging in frontotemporal lobar degeneration.
    Russo G; Russo MJ; Buyatti D; Chrem P; Bagnati P; Fernández Suarez M; Campos J; Cohen G; Amengual A; Allegri RF; Knopman DS
    J Neurol Sci; 2014 Sep; 344(1-2):63-8. PubMed ID: 25015844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort.
    Gentry MT; Lapid MI; Syrjanen J; Calvert K; Hughes S; Brushaber D; Kremers W; Bove J; Brannelly P; Coppola G; Dheel C; Dickerson B; Dickinson S; Faber K; Fields J; Fong J; Foroud T; Forsberg L; Gavrilova R; Gearhart D; Ghoshal N; Goldman J; Graff-Radford J; Graff-Radford N; Grossman M; Haley D; Heuer H; Hsiung GY; Huey E; Irwin D; Jones D; Jones L; Kantarci K; Karydas A; Knopman D; Kornak J; Kramer J; Kukull W; Lucente D; Lungu C; Mackenzie I; Manoochehri M; McGinnis S; Miller B; Pearlman R; Petrucelli L; Potter M; Rademakers R; Ramos EM; Rankin K; Rascovsky K; Sengdy P; Shaw L; Tatton N; Taylor J; Toga A; Trojanowski J; Weintraub S; Wong B; Wszolek Z; Boeve BF; Boxer A; Rosen H;
    Alzheimers Dement; 2020 Aug; 16(8):1115-1124. PubMed ID: 32656921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog.
    Poos JM; Moore KM; Nicholas J; Russell LL; Peakman G; Convery RS; Jiskoot LC; van der Ende E; van den Berg E; Papma JM; Seelaar H; Pijnenburg YAL; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia C; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tiraboschi P; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Le Ber I; Pasquier F; van Swieten JC; Rohrer JD;
    Alzheimers Res Ther; 2022 Jan; 14(1):10. PubMed ID: 35045872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and Reliability of the Frontotemporal Dementia Rating Scale (FTD-FRS) for the Progression and Staging of Dementia in Brazilian Patients.
    Lima-Silva TB; Bahia VS; Cecchini MA; Cassimiro L; Guimarães HC; Gambogi LB; Caramelli P; Balthazar M; Damasceno B; Brucki SMD; de Souza LC; Nitrini R; Mioshi E; Yassuda MS
    Alzheimer Dis Assoc Disord; 2018; 32(3):220-225. PubMed ID: 29438114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales.
    Samra K; MacDougall AM; Peakman G; Bouzigues A; Bocchetta M; Cash DM; Greaves CV; Convery RS; van Swieten JC; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia C; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Le Ber I; Tiraboschi P; Santana I; Pasquier F; Levin J; Otto M; Sorbi S; Rohrer JD; Russell LL;
    J Neurol; 2023 Mar; 270(3):1466-1477. PubMed ID: 36385202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting clinical change with the CDR-FTLD: differences between FTLD and AD dementia.
    Mioshi E; Flanagan E; Knopman D
    Int J Geriatr Psychiatry; 2017 Sep; 32(9):977-982. PubMed ID: 27464599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontotemporal Lobar Degeneration-Modified Clinical Dementia Rating (FTLD-CDR) Scale and Frontotemporal Dementia Rating Scale (FRS) Correlation With Regional Brain Perfusion in a Series of FTLD Patients.
    Maiovis P; Ioannidis P; Gerasimou G; Gotzamani-Psarrakou A; Karacostas D
    J Neuropsychiatry Clin Neurosci; 2017; 29(1):26-30. PubMed ID: 27417072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.